V2 sact_regimen
781,388 rows · 12 columns
| ENCORE_PATIENT_ID | MERGED_REGIMEN_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | BENCHMARK_GROUP | LINK_NUMBER |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 250002417 | 250006068 | null | null | Palliative (P) | null | 2016-10-23 | null | null | N | ENZALUTAMIDE | 101027279 |
| 250002418 | 250006069 | null | null | Palliative (P) | 2019-04-10 | 2019-04-21 | null | 02 | null | CARBOPLATIN + PACLITAXEL | 100791418 |
| 250002421 | 250006071 | 0 | 92.2 | null | 2021-02-14 | 2021-02-27 | Irinotecan + Temozolomide | 02 | N | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101452322 |
| 250002429 | 250006073 | 1.77 | 52.2 | Palliative (P) | null | 2019-09-30 | null | 02 | N | GEMCITABINE | 100005118 |
| 250002431 | 250006075 | 1.55 | 66.3 | Palliative (P) | 2019-08-05 | 2019-08-05 | null | 02 | null | CETUXIMAB | 100930843 |
| 250002433 | 250006077 | null | null | Palliative (P) | 2018-11-16 | 2018-11-16 | NB HRNBL-1 ch14.18/CHO only (trial) | 01 | N | NOT MATCHED | 101423039 |
| 250002437 | 250006079 | 1.52 | 54.5 | Adjuvant (A) | 2017-02-16 | 2017-02-27 | Doxorubicin + Ifosfamide | N | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 101580033 |
| 250002439 | 250006080 | 1.9 | null | Palliative (P) | 2018-02-19 | 2018-02-26 | null | 02 | N | AVELUMAB + AXITINIB | 101632708 |
| 250002440 | 250006081 | 1.67 | null | null | 2018-04-21 | 2018-04-21 | null | 02 | N | ATEZOLIZUMAB | 101694139 |
| 250002442 | 250006082 | 1.75 | 94.3 | null | 2018-01-17 | 2018-01-19 | FLUOROURACIL + MITOMYCIN + RT | 01 | N | CISPLATIN + RT | 100267875 |
| 250002445 | 250006084 | 1.66 | 52.2 | null | null | 2017-04-09 | CARBOPLATIN | 02 | N | TRIAL UNSPECIFIED | 101186520 |
| 250002447 | 250006085 | null | null | Palliative (P) | 2020-03-26 | 2020-04-14 | null | 02 | null | STS RHABDOMYOSARCOMA RMS 2005 IVA | 101220723 |
| 250002453 | 250006086 | 1.75 | 114.3 | null | 2020-02-18 | 2020-03-01 | Carboplatin + Etoposide iv&po | 02 | N | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 101061103 |
| 250002456 | 250006087 | null | null | Palliative (P) | 2020-03-28 | 2020-04-05 | NB HRNBL-1 ch14.18/CHO only (trial) | 02 | N | DOCETAXEL + GEMCITABINE | 100222511 |
| 250002460 | 250006088 | 1.81 | 95.9 | null | 2019-12-18 | 2020-01-07 | null | 02 | N | CETUXIMAB | 100235580 |
| 250002461 | 250006089 | 1.78 | 24.1 | null | 2018-01-09 | 2018-01-17 | Doxorubicin + Olaratumab | 02 | N | TRABECTEDIN | 100609042 |
| 250002464 | 250006090 | 1.9 | 0 | Palliative (P) | 2019-03-04 | 2019-03-05 | null | N | N | PAZOPANIB | 100226924 |
| 250002465 | 250006091 | 1.63 | 100.6 | Palliative (P) | 2018-05-23 | 2018-05-24 | NB HRNBL-1 COJEC Ind COURSE B | 02 | null | WT GUIDELINES CYCLOPHOS/DOXORUBICIN | 100402797 |
| 250002469 | 250006094 | 1.67 | null | Palliative (P) | 2021-11-30 | 2022-03-08 | null | 02 | N | CAPECITABINE + OXALIPLATIN | 100269129 |
| 250002471 | 250006096 | null | null | 03 | null | 2019-05-14 | CARBOPLATIN + ETOPOSIDE | null | null | TRABECTEDIN | 101703030 |
| 250002473 | 250006098 | 1.02 | 54 | Palliative (P) | 2020-10-13 | 2021-02-15 | null | 02 | N | CARBOPLATIN + VINORELBINE | 101623147 |
| 250002475 | 250006099 | 1.74 | 82.5 | Palliative (P) | 2019-08-09 | 2019-08-18 | null | null | N | CAPECITABINE + OXALIPLATIN | 100550452 |
| 250002476 | 250006100 | null | null | null | null | 2018-05-15 | null | null | null | IPILIMUMAB | 100545806 |
| 250002487 | 250006105 | null | null | null | 2017-12-18 | 2017-12-29 | null | 02 | null | IMATINIB | 100660762 |
| 250002488 | 250006106 | 1.66 | 67.7 | null | 2020-02-07 | 2020-02-14 | Oxaliplatin + Modified de Gramont | 02 | N | TRIAL UNSPECIFIED | 101074717 |
| 250002491 | 250006108 | 1.86 | 73.2 | null | 2019-03-21 | 2020-01-25 | Carboplatin AUC 2 - 5 | 02 | N | CARBOPLATIN | 100953347 |
| 250002492 | 250006109 | null | null | null | null | 2019-10-15 | VDC | null | N | BACILLUS CALMETTE-GUERIN | 100743337 |
| 250002495 | 250006112 | 1.73 | 79 | null | 2020-01-15 | 2020-02-08 | CARBOPLATIN + PACLITAXEL | 02 | N | CISPLATIN + FLUOROURACIL | 101263192 |
| 250002496 | 250006113 | 1.78 | 54.9 | null | null | 2021-02-05 | VDC | null | null | GEMCITABINE | 101022174 |
| 250002499 | 250006115 | 1.54 | 83.5 | Palliative (P) | 2018-11-07 | 2018-11-07 | null | 02 | N | ENZALUTAMIDE | 101290057 |
| 250002500 | 250006116 | 1.69 | 118.7 | Palliative (P) | 2020-11-07 | 2020-11-07 | GemCarbo Days 1+8 | 02 | null | IPILIMUMAB + NIVOLUMAB | 100016781 |
| 250002502 | 250006118 | 0 | null | null | 2020-01-09 | 2020-01-10 | CISPLATIN + VINORELBINE | 02 | N | CARBOPLATIN + PEMETREXED | 100633098 |
| 250002506 | 250006121 | 1.58 | 45 | null | 2018-09-29 | 2018-10-19 | null | 02 | null | CARBOPLATIN + PEMETREXED | 100352838 |
| 250002507 | 250006122 | 1.61 | 89.9 | Palliative (P) | 2020-05-20 | 2020-05-28 | null | 02 | null | NOT MATCHED | 100110559 |
| 250002508 | 250006123 | 1.87 | 46 | null | 2018-03-05 | 2018-03-13 | null | 02 | N | FLUOROURACIL + IRINOTECAN | 101008267 |
| 250002509 | 250006124 | 0 | 73.2 | null | 2019-12-14 | 2019-12-15 | Trial Unspecified | 02 | N | BLEOMYCIN + CISPLATIN + ETOPOSIDE | 100413560 |
| 250002512 | 250006125 | 1.82 | 70.4 | null | 2018-10-17 | 2018-10-20 | null | 02 | null | FLUOROURACIL + MITOMYCIN | 101653937 |
| 250002516 | 250006127 | null | null | Palliative (P) | 2021-08-26 | 2021-08-26 | CARBOPLATIN + Cetuximab + FLUOROURACIL | 02 | null | BEVACIZUMAB | 100028319 |
| 250002518 | 250006129 | 1.8 | 66.7 | 03 | null | 2016-08-01 | CETUXIMAB | N | N | ATEZOLIZUMAB | 100113525 |
| 250002524 | 250006132 | 1.83 | 70.4 | null | 2020-10-06 | 2020-10-06 | CARBOPLATIN + ETOPOSIDE | 01 | N | CISPLATIN + DOCETAXEL + FLUOROURACIL | 101406783 |
| 250002525 | 250006133 | 1.81 | 61.9 | null | null | 2021-05-09 | Trabectedin | 02 | N | IMATINIB | 100606801 |
| 250002527 | 250006134 | 1.8 | 66.8 | Palliative (P) | 2019-03-09 | 2019-03-26 | null | 02 | N | NB HRNBL-1 CH14.18/CHO ONLY (TRIAL) | 101435304 |
| 250002534 | 250006139 | null | null | Curative (C) | 2018-10-07 | 2019-08-23 | Tivozanib | 02 | N | CARBOPLATIN + PACLITAXEL | 100519516 |
| 250002542 | 250006144 | 1.8 | 84.8 | Palliative (P) | 2019-11-01 | 2019-11-01 | Cisplatin + Radiotherapy + CISPLATIN | 02 | N | CISPLATIN | 100803641 |
| 250000037 | 250006147 | 1.71 | 70.4 | 02 | 2018-02-03 | 2018-02-03 | null | 02 | N | ETOPOSIDE + IFOSFAMIDE | 100063593 |
| 250000218 | 250006152 | null | null | Palliative (P) | null | 2017-08-12 | NB HRNBL-1 ch14.18/CHO(trial) +IL-2 | null | N | CARBOPLATIN + PACLITAXEL | 101444568 |
| 250000328 | 250006155 | null | null | null | null | 2018-09-23 | Cisplatin | null | null | TRIAL UNSPECIFIED | 100222763 |
| 250000410 | 250006157 | null | null | Palliative (P) | 2019-08-12 | 2019-11-17 | null | 02 | N | TRABECTEDIN | 101474441 |
| 250000744 | 250006163 | 0 | 12.6 | Palliative (P) | 2019-01-17 | 2019-02-07 | TEMOZOLOMIDE | 02 | N | CABOZANTINIB | 101856875 |
| 250000752 | 250006164 | null | null | Palliative (P) | 2020-01-05 | 2020-01-05 | Docetaxel | 02 | null | CARBOPLATIN + CETUXIMAB + FLUOROURACIL | 100655978 |